RxDoctor Payments Data

Aaron Fischman, MD

Vascular & Interventional Radiology · New York, NYNPI 1699934844

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $171,445 of the $239,558 with a category attached, or 71.6%. 20 manufacturers reported payments, led by Terumo Medical Corporation at 34.8% of the total. 2025 is the largest year on record at $61,213, 2.9 times the $21,359 reported in 2019. Among vascular & interventional radiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$239,558in general payments, 2019–2025

Across 282 payments — averaging $849.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Terumo Medical Corporation$83K
  • Boston Scientific$64K
  • Embolx, Inc.$38K
  • Sirtex Medical Inc$21K
  • Siemens Medical Solutions USA, Inc.$20K
  • Guerbet LLC$6K
  • plus $7K from 14 others
$328,536in research payments, 2019–2025

Across 45 payments — averaging $7300.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$150K
  • Boston Scientific$106K
  • Instylla, Inc.$69K
  • Biocompatibles, Inc.$3K

What the payments were for

  • Consulting fees$171,44572%
  • Speaking & faculty fees$37,40016%
  • Travel & lodging$23,66110%
  • Food & beverage$7,0513%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$239,558 in reported general payments places this provider in the 95th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York

Medicare billing

Part B allowed, 2024
$252,800
Medicare patients
365
Services billed
10,761

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →